Skip to main content

Table 1 Baseline characteristics of participants

From: Multipredictor risk models for predicting individual risk of Alzheimer’s disease

 

CN (n = 487)

MCI (n = 796)

ADNI 1

ADNI 2

ADNI 1

ADNI 2

ADNI GO

n

214

273

360

317

119

Number of events

72

67

206

96

19

Follow-up period (years)

5.1 (3.3)

3.8 (1.9)

4.84 (3.1)

3.9 (1.8)

5.3 (2.0)

Age (years)

75.9 (5.1)

73.0 (6.0)

74.8 (7.3)

70.5 (7.3)

71.85 (8.9)

Sex (F/M)

103/111

147/126

129/231

143/174

54/65

Education (years)

16.1 (2.8)

16.6 (2.5)

15.7 (3.0)

15.92.6

15.17 (2.7)

APOE ε4 carriers (0/1/2)

156/54/4

189/78/6

167/150/43

157/123/37

70/41/8

MMSE

29.1 (1.0)

29.0 (1.2)

27.1 (1.8)

28.1 (1.7)

28.3 (1.7)

ADAS11

6.1 (3.0)

5.7 (2.9)

11.42 (4.4)

9.3 (4.6)

7.5 (3.3)

RAVLT immediate

43.7 (9.0)

45.6 (10.3)

31.0 (9.2)

39.7 (11.1)

42.39 (11.1)

FAQ

0.14 (0.6)

0.3 (1.1)

3.8 (4.5)

2.6 (3.8)

1.0 (1.7)

LM-DR

13.0 (3.5)

13.3 (3.1)

3.9 (2.7)

6.2 (3.4)

8.3 (1.8)

Plasma tau (pg/ml)

2.7 (1.6)

NA*

2.9 (1.7)

NA*

NA*

Plasma NFL (pg/ml)

35.1 (22.0)

29.0 (7.8)

42.6 (27.8)

38.3 (17.9)

38.8 (21.3)

White matter hyperintensities (mm3)

0.8 (2.2)

6.3 (10.6)

0.8 (2.5)

6.2 (8.3)

7.5 (10.0)

Hippocampus volume (cm3)

7.2 (0.9)

7.6 (0.8)

6.4 (1.0)

6.9 (1.1)

7.2 (1.0)

Whole brain volume (cm3)

1004.0 (55.5)

1073.4 (64.2)

977.5 (63.9)

1046.4 (64,3)

1069.6 (50.8)

Entorhinal volume (cm3)

3.8 (0.7)

3.9 (0.6)

3.3 (0.7)

3.5 (0.7)

3.7 (0.6)

Middle temporal lobe volume (cm3)

19.6 (2.1)

21.0 (2.3)

18.5 (2.5)

19.8 (2.4)

20.8 (2.1)

Ventricles volume (cm3)

35.2 (16.6)

35.2 (16.6)

41.2 (20.2)

38.2 (18.7)

38.0 (19.3)

CSF Aβ (pg/ml)

207.6 (52.0)

198.2 (49.7)

199.0 (52.1)

175.4 (51.5)

192.2 (48.4)

CSF tau (pg/ml)

69.0 (26.3)

66.2 (32.9)

100.5 (52.2)

98.4 (52.5)

84.2 (58.7)

CSF p-tau (pg/ml)

26.4 (14.2)

35.2 (19.2)

35.82 (22.8)

45.6 (25.1)

34.2 (19.8)

BMI

26.4 (4.5)

27.7 (5.0)

25.99 (4.0)

27.3 (5.2)

28.3 (5.6)

Cholesterol (mg/dl)

193.2 (40.4)

190.9 (39.4)

197.4 (39.2)

208.0 (37.1)

210.4 (39.7)

Systolic blood pressure (mmHg)

132.9 (16.0)

133.8 (16.0)

133.1 (17.0)

130.1 (17.6)

134.8 (18.2)

History of diabetes (%)

13 (6.1%)

25 (9.2%)

24 (6.7%)

33 (10.4%)

12 (10.1%)

History of hypertension (%)

96 (44.9%)

127 (46.5%)

176 (48.9%)

147 (46.4%)

56 (47.1%)

History of depression (%)

35 (16.4%)

59 (21.6%)

103 (28.6%)

118 (37.2%)

29 (24.4%)

  1. Summarized as mean ± standard deviation (SD) for continuous data and count and percentage (%) for categorical data
  2. ADAS11 Alzheimer’s Disease Assessment Scale with 11 items, BMI body mass index, CSF cerebrospinal fluid, FAQ Functional Assessment Questionnaire, MMSE Mini Mental State Examination, p-tau phosphorylated Tau, RAVLT Rey's Auditory Verbal Learning Test
  3. *Data of plasma tau was available from ADNI 1 participants only